Article Cited by others

RESEARCH PAPER

Treatment outcome of standardized regimen in patients with multidrug resistant tuberculosis

Jain Kalpesh, Desai Mira, Solanki Rajesh, Dikshit Ram Kumar

Year : 2014| Volume: 5| Issue : 2 | Page no: 145-149

   This article has been cited by
 
1 Clinical outcome of multidrug-resistant tuberculosis patients receiving standardized second-line treatment regimen in China
Caihong Xu,Yu Pang,Renzhong Li,Yunzhou Ruan,Lixia Wang,Mingting Chen,Hui Zhang
Journal of Infection. 2018;
[Pubmed]  [Google Scholar] [DOI]
2 Factors predicting treatment success in multi-drug resistant tuberculosis patients treated under programmatic conditions
A.K. Janmeja,Deepak Aggarwal,Ruchika Dhillon
Indian Journal of Tuberculosis. 2018;
[Pubmed]  [Google Scholar] [DOI]
3 Comorbidities and treatment outcomes in multidrug resistant tuberculosis: a systematic review and meta-analysis
Joel Philip Samuels,Aashna Sood,Jonathon R. Campbell,Faiz Ahmad Khan,James Cameron Johnston
Scientific Reports. 2018; 8(1)
[Pubmed]  [Google Scholar] [DOI]
4 Treatment outcomes for multidrug-resistant tuberculosis under DOTS-Plus: a systematic review and meta-analysis of published studies
Kelemu Tilahun Kibret,Yonatan Moges,Peter Memiah,Sibhatu Biadgilign
Infectious Diseases of Poverty. 2017; 6(1)
[Pubmed]  [Google Scholar] [DOI]
5 Current and developing therapies for the treatment of multi drug resistant tuberculosis (MDR-TB) in India
Malaisamy Muniyandi,Rajeswari Ramachandran
Expert Opinion on Pharmacotherapy. 2017; 18(13): 1301
[Pubmed]  [Google Scholar] [DOI]
6 Association between Directly Observed Therapy and Treatment Outcomes in Multidrug-Resistant Tuberculosis: A Systematic Review and Meta-Analysis
Jia Yin,Jinqiu Yuan,Yanhong Hu,Xiaolin Wei,Pere-Joan Cardona
PLOS ONE. 2016; 11(3): e0150511
[Pubmed]  [Google Scholar] [DOI]
7 Study of factors influencing response and outcome of Cat-IV regimen in MDRTB patients
Arun Kumar Yadav,Ashok Kumar Mehrotra,S.P. Agnihotri,Shivani Swami
Indian Journal of Tuberculosis. 2016;
[Pubmed]  [Google Scholar] [DOI]
8 Impact of rapid molecular diagnostic tests on time to treatment initiation and outcomes in patients with multidrug-resistant tuberculosis, Tamil Nadu, India
Dina Nair,Pooranaganga D. Navneethapandian,Jaya Prasad Tripathy,Anthony D. Harries,Joel S. Klinton,Basilea Watson,Gomathi N. Sivaramakrishnan,Devarajulu S. Reddy,Lakshmi Murali,Mohan Natrajan,Soumya Swaminathan
Transactions of The Royal Society of Tropical Medicine and Hygiene. 2016; 110(9): 534
[Pubmed]  [Google Scholar] [DOI]
9 Efficacy and effect of free treatment on multidrug-resistant tuberculosis
QING ZHANG,ZHEYUAN WU,ZURONG ZHANG,WEI SHA,XIN SHEN,HEPING XIAO
Experimental and Therapeutic Medicine. 2016; 11(3): 777
[Pubmed]  [Google Scholar] [DOI]
10 Prognostic factors of treatment among patients with multidrug-resistant tuberculosis in Egypt
Mohsen A. Gadallah,Alaa Mokhtar,Mervat Rady,Essam El-Moghazy,Magdy Fawzy,Sahar Khalil Kandil
Journal of the Formosan Medical Association. 2015;
[Pubmed]  [Google Scholar] [DOI]
11 Cigarette Smoking Impairs Human Pulmonary Immunity toMycobacterium tuberculosis
Seónadh M. O’Leary,Michelle M. Coleman,Wui Mei Chew,Colette Morrow,Anne Marie McLaughlin,Laura E. Gleeson,Mary P. O’Sullivan,Joseph Keane
American Journal of Respiratory and Critical Care Medicine. 2014; 190(12): 1430
[Pubmed]  [Google Scholar] [DOI]

 

Read this article